A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
Ying Fu(National Institutes of Health), Anton Simeonov(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Quinlin Hanson(National Institutes of Health), Richard T. Eastman(National Institutes of Health), Shelley Perkins(Protein Express (United States)), Manisha Pradhan(National Institutes of Health), Juliana da Fonseca Rezende e Mello(National Institutes of Health), William Gillette(Protein Express (United States)), Matthew D. Hall(National Institutes of Health), Emily M. Lee(Florida State University), Venkata P. Dandey(Triangle), Wei Zheng(Liaoning Cancer Hospital & Institute), Mario J. Borgnia(National Institutes of Health), Zina Itkin(National Institutes of Health), Nitya Ramakrishnan(Protein Express (United States)), Kedar Sharma(National Institutes of Health), Allen L. Hsu(National Institutes of Health), Kirill Gorshkov(National Center for Advancing Translational Sciences), Thomas B. Stanley(National Institute of Environmental Health Sciences), Robert M. Petrovich(National Institutes of Health), Mason A. Wolak(United States Naval Research Laboratory), Kimihiro Susumu(Sotera Defense Solutions (United States)), Dominic Esposito(Leidos (United States)), Troy Taylor(Protein Express (United States)), Alex Renn(National Institutes of Health), Bryan D. Fleming(University of Maryland, College Park), Miao Xu(National Institutes of Health), Xin Hu(Discovery Institute), Eunkeu Oh(Sotera Defense Solutions (United States)), Lalith Perera(National Institutes of Health), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition)
Cited by 18
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
|Cancer Discovery|2017|336